货号:A361358
同义名:
3-(甲基硒基)-L-丙氨酸
/ Methylselenocysteine; Se-Methylseleno-L-cysteine
H-3-(Me-Se)-Ala-OH是甲基硒的前体,表现出强大的化学预防和抗氧化活性,能够通过诱导细胞凋亡抑制癌细胞增殖,具有良好的口服生物活性。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | ALK1 ↓ ↑ | ALK2 ↓ ↑ | ALK3 ↓ ↑ | ALK4 ↓ ↑ | ALK6 ↓ ↑ | Smad3 ↓ ↑ | TGF-β ↓ ↑ | TGFβRI/ALK5 ↓ ↑ | TGFβRII ↓ ↑ | 其他靶点 | 纯度 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LDN193189 |
++++
ALK1, IC50: 0.8 nM |
++++
ALK2, IC50: 0.8 nM |
+++
ALK3, IC50: 5.3 nM |
+++
ALK6, IC50: 16.7 nM |
99%+ | ||||||||||||||
| LDN-212854 |
++++
ALK1, IC50: 2.4 nM |
++++
ALK2, IC50: 1.3 nM |
+
ALK3, IC50: 85.8 nM |
+
ALK4, IC50: 2133 nM |
+
ALK5, IC50: 9276 nM |
99%+ | |||||||||||||
| ML347 |
++
ALK1, IC50: 46 nM |
++
ALK2, IC50: 32 nM |
98% | ||||||||||||||||
| K02288 |
++++
ALK1, IC50: 1.8 nM |
++++
ALK2, IC50: 1.1 nM |
++
ALK3, IC50: 34.4 nM |
+++
ALK6, IC50: 6.4 nM |
99%+ | ||||||||||||||
| LDN-193189 2HCl |
++++
ALK1, IC50: 0.8 nM |
++++
ALK2, IC50: 0.8 nM |
+++
ALK3, IC50: 5.3 nM |
+++
ALK6, IC50: 16.7 nM |
99% | ||||||||||||||
| LDN-214117 |
++
ALK2, IC50: 24 nM |
98% | |||||||||||||||||
| DMH-1 |
+
ALK2, IC50: 107.9 nM |
99%+ | |||||||||||||||||
| SB-505124 |
+
ALK4, IC50: 129 nM |
++
ALK5, IC50: 47 nM |
99%+ | ||||||||||||||||
| Vactosertib |
+++
ALK4, IC50: 13 nM |
+++
ALK5, IC50: 11 nM |
99%+ | ||||||||||||||||
| Alantolactone | ✔ | 98% | |||||||||||||||||
| (E/Z)-SIS3 free base | ✔ | 97% | |||||||||||||||||
| Pirfenidone | ✔ | 98% | |||||||||||||||||
| Hesperetin | ✔ | 97% | |||||||||||||||||
| RepSox |
++++
TGFβR1(ALK5), IC50: 4 nM |
98% | |||||||||||||||||
| GW788388 |
+++
ALK5, IC50: 18 nM |
98% | |||||||||||||||||
| LY364947 |
++
TGFβRI, IC50: 59 nM |
+
TGFβRII, IC50: 0.4 μM |
98% | ||||||||||||||||
| SD-208 |
++
TGF-βRI (ALK5), IC50: 48 nM |
99% | |||||||||||||||||
| SB-525334 |
+++
TGFβR1(ALK5), IC50: 14.3 nM |
99%+ | |||||||||||||||||
| LY2109761 |
++
TβRI, Ki: 38 nM |
+
TβRII, Ki: 300 nM |
99%+ | ||||||||||||||||
| Galunisertib |
++
TβRI, IC50: 56 nM |
98% | |||||||||||||||||
| SB 431542 |
+
ALK5, IC50: 94 nM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Se-Methylselenocysteine has strong cancer chemopreventive activity and antioxidant activity. Se-Methylselenocysteine is orally active and induces apoptosis[1][2].Acting in the concentration range of 100-400 μM for 3 days, Se-Methylselenocysteine induced caspase-3-mediated apoptosis in SKOV-33 cells, leading to a significant increase in sub-G1 phase accumulation[1][2]. |
| Concentration | Treated Time | Description | References | |
| Caenorhabditis elegans (C. elegans) | 100 μM | 18 h | To study the bioavailability, protein incorporation, and modulation of the antioxidant defense system by Se-Methylselenocysteine. Results showed that all tested selenium compounds were bioavailable, but only SeMet persistently accumulated and was non-specifically incorporated into proteins. However, the protection against chemically-induced reactive species formation was independent of the applied selenium compound. | Mol Nutr Food Res. 2019 May;63(9):e1801304 |
| HuH-28 (cholangiocarcinoma cell line) | 15, 30, 60, 120 μM | 72 hours | Measure miRNA expression changes, results showed increased miR-122, -199a | Pathol Oncol Res. 2020 Oct;26(4):2669-2681 |
| TFK-1 (cholangiocarcinoma cell line) | 240, 480, 960 μM | 72 hours | Measure miRNA expression changes, results showed increased miR-143 | Pathol Oncol Res. 2020 Oct;26(4):2669-2681 |
| HLF (hepatocellular carcinoma cell line) | 15, 30, 60, 120 μM | 72 hours | Measure miRNA expression changes, results showed increased miR-122 and decreased miR-199a | Pathol Oncol Res. 2020 Oct;26(4):2669-2681 |
| HMEC cells | 1500 ng Se/mL | 24, 48, 72, and 96 h | Evaluate the effects of Se-Methylselenocysteine on the growth of HMEC cells. Results showed that MSC at 1500 ng Se/mL did not significantly inhibit the growth of HMEC cells. | Int J Med Sci. 2015 Sep 5;12(9):748-58 |
| MDA-MB-231 cells | 1500 ng Se/mL | 24, 48, 72, and 96 h | Evaluate the effects of Se-Methylselenocysteine on growth inhibition and apoptosis in MDA-MB-231 cells. Results showed that MSC at 1500 ng Se/mL inhibited the growth of MDA-MB-231 cells, but the effect was lower than MSA. | Int J Med Sci. 2015 Sep 5;12(9):748-58 |
| MCF-7 cells | 1500 ng Se/mL | 24, 48, 72, and 96 h | Evaluate the effects of Se-Methylselenocysteine on growth inhibition and apoptosis in MCF-7 cells. Results showed that MSC at 1500 ng Se/mL inhibited the growth of MCF-7 cells, but the effect was lower than MSA. | Int J Med Sci. 2015 Sep 5;12(9):748-58 |
| HepG2 cells | 1.25~20 µg/mL | 24 hours | Evaluate the effect of MSC on glucose consumption in HepG2 cells, results showed MSC (5 µg/mL) significantly increased glucose consumption | Molecules. 2023 Jul 19;28(14):5499 |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | 786.0 renal cell carcinoma xenograft model | Oral | 10 mg/kg | Once daily for 7 days | To evaluate the antitumor activity of MSC in the 786.0 renal cell carcinoma xenograft model, results showed that MSC selectively stabilized tumor vasculature and enhanced the efficacy of subsequent treatments | Int J Mol Sci. 2018 Oct 29;19(11):3378 |
| Caenorhabditis elegans (C. elegans) | Wildtype and txnrd-1 deletion mutants | Hatch incubation | 100 μM | Single dose, 18 hours | To evaluate the protective effects of Se-Methylselenocysteine against oxidative stress and its modulation of the antioxidant defense system. Results showed that Se-Methylselenocysteine protected wildtype C. elegans from chemically-induced reactive oxygen and nitrogen species (RONS) formation, but no protective effect was observed in txnrd-1 deletion mutants. | Mol Nutr Food Res. 2019 May;63(9):e1801304 |
| C57BL/6J mice | High-fat diet and streptozotocin-induced type 2 diabetes model | Oral | 6.5 or 13 µg/kg MSC | Once daily for four weeks | Evaluate the effect of TAC/MSC on blood glucose and lipid metabolism in type 2 diabetic mice, results showed TAC/MSC significantly improved hyperglycemia and lipid metabolism disorder | Molecules. 2023 Jul 19;28(14):5499 |
| Sprague-Dawley rats | DEN-induced hepatocellular carcinoma rat model | Oral | 0.3 mg/kg, 1 mg/kg, 3 mg/kg | 5 times per week for 6 consecutive weeks | MSC treatment significantly alleviated liver injury and nuclear lesions, improved liver function, decreased CD34 expression and NO/NOS levels, and suppressed VEGF expression. | Med Sci Monit. 2021 Aug 4;27:e929255 |
| Animal study | Se-Methylselenocysteine, administered orally once daily for 14 days at a dose of 0.2 mg/mouse, potentiated the antitumour activity of CDDP and cyclophosphamide in nude mice bearing human FaDu and A253 head and neck xenografts[2]. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
5.49mL 1.10mL 0.55mL |
27.46mL 5.49mL 2.75mL |
54.92mL 10.98mL 5.49mL |
|
| CAS号 | 26046-90-2 |
| 分子式 | C4H9NO2Se |
| 分子量 | 182.08 |
| SMILES Code | O=C(O)[C@@H](N)C[Se]C |
| MDL No. | MFCD00800565 |
| 别名 | 3-(甲基硒基)-L-丙氨酸 ;Methylselenocysteine; Se-Methylseleno-L-cysteine; SeMCys; Se-MSC; MSeC; Se-Methylselenocysteine |
| 运输 | 蓝冰 |
| InChI Key | XDSSPSLGNGIIHP-VKHMYHEASA-N |
| Pubchem ID | 147004 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
H2O: 85 mg/mL(466.83 mM),配合低频超声助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1